Equillium Inc
NASDAQ:EQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Equillium Inc
NASDAQ:EQ
|
US |
|
L
|
Laboratorios Richmond SACIF
BCBA:RICH
|
AR |
|
C
|
Capital Engineering Network PCL
SET:CEN
|
TH |
|
abrdn Property Income Trust Ltd
LSE:API
|
GG |
Intrinsic Value
Is EQ undervalued or overvalued?
See the intrinsic value estimate for Equillium Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
EQ looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with EQ’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Equillium Does
Equillium is a clinical-stage biopharmaceutical company that develops medicines for severe autoimmune and inflammatory diseases. Its main focus is on drugs that calm an overactive immune system, especially in conditions where the body attacks its own tissues or causes dangerous inflammation.
- Headquarters
- United States of America US
- Employees
- 15
- IPO date
- Oct 12, 2018
Revenue & Expenses Breakdown
Equillium Inc
Earnings Waterfall
Equillium Inc
The intrinsic value for Equillium Inc (EQ) under the Base Case is hidden USD.
Compared with the current market price of 1.36 USD, the stock appears hidden.